OncoCyte Stock (NASDAQ: OCX) stock price, news, charts, stock research, profile.
Open | $3.17 |
Close | $3.11 |
Volume / Avg. | 5.22K / 36.12K |
Day Range | $2.91 - $3.22 |
52 Wk Range | 2.08 - 4.34 |
Market Cap | $38.90M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 1.71% |
Days to Cover | 11.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of OncoCyte (NASDAQ:OCX) through any online brokerage.
Other companies in OncoCyte’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Acurx Pharmaceuticals (NASDAQ:ACXP) and Aligos Therapeutics (NASDAQ:ALGS).
OncoCyte has a consensus price target of $3.35.
The stock price for OncoCyte (NASDAQ: OCX) is $2.91 last updated August 5, 2024 at 9:07 AM EDT.
There are no upcoming dividends for OncoCyte.
OncoCyte’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for OncoCyte.
OncoCyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.